2-Cyano-3-trifluoromethylpyridine | CAS:406933-21-9

We serve 2-Cyano-3-trifluoromethylpyridine CAS:406933-21-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Cyano-3-trifluoromethylpyridine

Chemical Name:2-Cyano-3-trifluoromethylpyridine
CAS.NO:406933-21-9
Synonyms:2-Cyano-3-trifluoromethylpyridine
3-(trifluoromethyl)pyridine-2-carbonitrile
3-(Trifluoromethyl)picolinonitrile
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 240.5±35.0 °C at 760 mmHg
Molecular Formula C7H3F3N2
Molecular Weight 172.107
Flash Point 99.2±25.9 °C
 
Specification:
Appearance:White powder or colorless liquid
Assay:≥96.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-Cyano-3-trifluoromethylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(Trifluoromethyl)picolinonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(Trifluoromethyl)picolinonitrile Use and application,2-Cyano-3-trifluoromethylpyridine technical grade,usp/ep/jp grade.


Related News: A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan.(2-butyl-5-nitro-1-benzofuran-3-yl)-(4-methoxyphenyl)methanone manufacturer It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.Trimethoxy(methyl)silane supplier The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.1-[(2-Bromophenyl)sulfanyl]-2,4-dimethylbenzene vendor Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.